Neural stimulation is a powerful technique for modulating physiological functions and for writing information into the nervous system as part of brain-machine interfaces. Current clinically approved neural stimulators require batteries and are many cubic centimeters in size-typically much larger than their intended targets. We present a complete wireless neural stimulation system consisting of a 2.2 mm 3 wireless, batteryless, leadless implantable stimulator (the "mote"), an ultrasonic wireless link for power and bi-directional communication, and a hand-held external transceiver. The mote consists of a piezoceramic transducer, an energy storage capacitor, and a stimulator integrated circuit (IC). The IC harvests ultrasonic power with high efficiency, decodes stimulation parameter downlink data, and generates current-controlled stimulation pulses. Stimulation parameters are time-encoded on the fly through the wireless link rather than being programmed and stored on the mote, enabling complex stimulation protocols with high-temporal resolution and closed-loop capability while reducing power consumption and on-chip memory requirements. Uplink data indicates whether the mote is currently stimulating; it is encoded by the mote via backscatter modulation and is demodulated at the external transceiver. We show that the system operates at an acoustic power one fifth the FDA limit for diagnostic ultrasound and is robust to expected real-world acoustic link misalignment. We investigate with motes implanted on the sciatic nerve of anesthetized rats and show the performance of the system highly repeatable stimulation across a wide range of physiological responses.
Extracellular electrophysiological stimulation is broadly applied to targets in the peripheral and central nervous system and has a long history of application both in neuroscience and clinical therapies. In the peripheral nervous system (PNS), the technique is well established for reinnervation of auditory sensory afferents using a cochlear implant 1 . More recent work has focused on creating devices that directly stimulate the PNS to regulate physiological functions 2 such as modulating blood pressure 3 , rheumatoid arthritis 4 , incontinence 5 , sexual function 6 , and immune system function 7 ; and reinnervating sensory afferents 8 and motor efferents 9 . Electrical stimulation of central nervous system (CNS) targets is well-established for treatment of chronic pain 10 and central motor disorders such as tremor in Parkinson's disease 11 with deep-brain stimulation (DBS). Recent work shows promising results for treatment of depression 12 , modulation of decision making 13 , and use in closed-loop brain-machine interfacing 14, 15 .
The application of clinical neural stimulators to therapies with small targets deep in tissue is currently limited by implant size, implantation risk, and longevity of the device-tissue interface. Current clinically deployed neural stimulators have a volume greater than 10 cm 3, 16, 17, 18 and consequently must be placed in large anatomical pockets. These pockets can be far from the stimulation site (e.g., subclavical to subthalamic nucleus) or require removing substantial soft tissue or bone to form a pocket (e.g. Neuropace RNS 18 ). Long leads are required from the stimulator housing to the stimulation site, which is a major source of infection, efficacy loss, and device failure 19 , in addition to electromagnetic interference, crosstalk, and power inefficiencies. Peripheral nerve cuffs which use wires to connect to a distant stimulator implant have shown detrimental effects due to strain on the nerve from the wire 20 , emphasizing the benefit of a completely untethered device. A stimulator of a couple cubic millimeters in size or less, comparable to a grain of sand, could be placed directly at the stimulation site rather than requiring leads, thus improving safety and substantially increasing access to anatomical sites. A highly miniaturized stimulator would enable ultra-minimally-invasive delivery methods such as laparoscopy or injection, reducing tissue trauma during implantation and immune response 21 .
A key challenge in developing wireless mm-scale stimulators is wireless power and communication that provides well-controlled, therapeutically relevant effects. To date, the smallest volume stimulators have been implemented with passive components, providing inefficient voltage-mode stimulation that is sensitive to received power and electrode impedance 22, 23 . Additionally, these stimulators do not have an uplink, preventing error detection or state monitoring via feedback to the external controller. Precise control of stimulation charge is important for targeting a repeatable population of cells and maintaining safety over chronic use. Neurostimulators employing integrated circuits can use active rectifiers to achieve a higher power conversion efficiency and deliver current stimulation that is independent of received power 24, 25, 26 . However, most active neurostimulators rely on a recovered clock from the high frequency wireless signal as well as programmed registers to generate stimulation waveform timing.
Significant division of the recovered clock results in power overhead and programming large registers limits the dynamic programmability of the waveform. Furthermore, most of these wireless systems use electromagnetic (EM) waves for power delivery and communication, which couples inefficiently at centimeter scales deep within tissue 27 . Fig. 1 | StimDust wireless neural stimulator system overview. a, Diagram depicting the StimDust system; here, it is used for stimulation of the sciatic nerve of a rat. b, The stimulating mote fully implanted and affixed to a rat sciatic nerve. Piezo at top, IC at bottom of mote. Stimulation pulses from the mote elicited compound action potentials in the nerve and compound muscle action potentials in the hindlimb musculature. c, Optional test leads on the mote were used for diagnostic and data reporting purposes to measure internal signals on the mote (also seen in (d)). They provided no power or control signals to the mote, and the mote function was verified with these leads disconnected from all external instrumentation. d, The wireless link traversed skin and muscle on top of a closed surgical site; this image shows the hindquarters of the animal superficial to the sciatic nerve. e, The external transceiver established an ultrasonic wireless link with the mote. The power and data cable is shown on the left and the external transducer is on the right.
Results

System Overview
A conceptual overview of the StimDust system and its implementation is shown in Fig. 1 . An external transceiver ( Fig. 1e ) established an ultrasonic wireless link through body tissue to an implanted StimDust mote (Fig. 1b, c) . A single ultrasonic link provided both power to the mote and bidirectional communication. The mote consisted of a piezoceramic as the ultrasonic transducer; a custom IC for power rectification, communication, and stimulation; a discrete capacitor for energy storage; bipolar stimulation electrodes; and a nerve cuff integrated on a thin polyimide printed circuit board (PCB). The mote was surgically implanted directly at the stimulation site, in this case the rat sciatic nerve (Fig. 1b) , the wound was closed (Fig. 1d) ; the transcutaneous wires are optional test leads), and the external transceiver was coupled to the outside surface of the body with ultrasound gel. The system could produce a broad set of clinically relevant stimulation currents, pulse widths, and pulse repetition frequencies (PRF); these were sufficient to elicit highly repeatable compound action potentials (CAPs) in the sciatic nerve, compound muscle action potentials (CMAPs), and associated twitches in downstream muscles.
Fig. 2 | StimDust system block diagram.
The external transceiver is depicted on the left, the ultrasonic wireless link in the middle, and the StimDust mote on the right. left, The external transceiver consisted of a transmit (Tx) path (lefttop) which encoded user-specified stimulation parameters onto a 1.85 MHz carrier wave, stepped up the voltage, and drove an external piezo transducer during the Tx sequence. A receive (Rx) path (left-middle) was activated when the Tx was not active and captured and demodulated the ultrasonic backscatter. middle, The ultrasonic wireless link traversed the body tissue between the external transceiver and the implanted mote. The downlink provided power and time-delay coded stimulation commands for stim amplitude [A], stim pulse width [W], interphase gap duration [G], and electrode shorting duration [S]. The uplink consisted of backscatter amplitude modulation. right, The implanted mote harvested power and decoded stim parameters from the downlink. A finite state machine set stimulation parameters, initiated the specified stim pulse, and activated a modulation switch on the piezo input to change its ultrasound reflectance and encode a backscatter uplink bit indicating stim state information.
A functional block diagram of the system is detailed in Fig. 2 . The external transceiver (Fig. 4g ) utilized a microcontroller to synthesize a low-voltage transmit signal, which encoded downlink stimulation parameters for each pulse onto a 1.85 MHz carrier. The low-voltage transmit signal from the microcontroller was stepped-up in voltage and drove the external piezoelectric ultrasound transducer.
During the 'off' periods of the transmit signal, the external transceiver toggled from Tx (transmit) to Rx (receive) mode to capture and demodulate uplink data from the acoustic signal backscattered by the mote. 
The implanted mote used an IC 35 to rectify energy harvested by the mote's piezo. Rectified energy was stored on an off-chip capacitor to ensure consistent operation of the IC during the 'off' cycles. The IC decoded received ultrasound to determine stimulation current amplitude, pulse width, interphase gap, and post-stimulation electrode shorting phase (passive recharge time). The mote delivered currentmode stimulation, during which the IC modulated the impedance across the piezo to change the amplitude of the reflected wave. This indicated to the external transceiver when the IC was stimulating and operating properly.
Protocol and implant design
The IC timing diagram and architecture are shown in Fig. 3a, b . The IC used a custom ultrasound protocol, which enabled dynamically controlled stimulation waveforms and high system efficiency while maintaining a high degree of timing control. The protocol utilized the shape of the incoming ultrasound envelope to encode stimulation parameters, eliminating the need for an on-chip, continuously running clock to ensure timing precision. This reduced power consumption and afforded greater stimulation waveform timing flexibility compared to solutions that rely on a clock receiver, divider circuits, and on-chip registers to generate the stimulation waveform 36, 24 . As shown in Fig. 3 , an initial power-up sequence charged the implant's storage capacitor, Cstore. As the supply voltage of the IC (VDD) ramped up to 2.5 V, a power-on-reset (POR) signal (threshold≈1.6 V) was generated to initialize the chip. If the POR signal was not generated, or VDD dropped below the threshold, the IC would not stimulate as a fail-safe against aberrant stimulation. In addition to the power-up sequence, the protocol was comprised of 4 repeating states: set amplitude (A), pulse width (W), interphase gap (G), and electrode shorting (S). Every state encoded information pertinent to the stimulation waveform interpreted by the IC and had a temporal resolution set by the carrier frequency (1/fcarrier = 540 ns). States A and G are called ultrasound-free intervals (UFI). A occurred during the first UFI and its duration encoded the stimulation amplitude. The watchdog timer circuit detected the UFI, which then triggered a 3-bit time-to-digital converter (TDC). The 3-bits of the TDC output were stored in memory for the stimulation pulse amplitude. W began when ultrasound returned and started a 16-cycle setup sequence to allow the current reference to settle prior to stimulation. On the 16 th cycle, a current mirror whose amplitude was set by the TDC was enabled by the output of the counter, Φstim, causing current to flow from the stimulation electrode to the return electrode.
Stimulation was terminated at the second UFI. During G, the chip was in standby mode and the stimulation electrode was tri-stated to create an interphase gap. Interphase gaps have been shown to decrease stimulation thresholds in auditory nerves, motor nerves, and retinal ganglion cells, in addition to decreasing perceptual thresholds in cochlear implant patients and epiretinal prosthesis patients 37, 38 .
State S started when ultrasound returned. During S, received ultrasound recharged the storage capacitor and the IC shorted the stimulation electrode to ground, clearing accumulated charge on the electrodes.
Since the charge cleared quickly, passive recharge 39 was favorable to conventional biphasic stimulation since it consumes half the energy without limiting stimulation frequency in this work. Furthermore, biphasic stimulators typically use an additional shorting phase to clear residual charge that accumulates from phase mismatch.
Whenever ultrasound was on (W and S), a fraction of the incident ultrasonic energy was reflected to the external transceiver (backscatter). The backscatter amplitude was a function of the electrical load of the mote piezo. The delay between transceiver emission and backscatter detection was twice the acoustic time-of-flight (~20-60µs) between the external transducer and the mote piezo. During stimulation, a transistor switch, Mmod (Fig. 3b ), was turned on to create a weak short (~4 kΩ) across the piezo terminals, reducing the amplitude of the backscatter signal ( Supplementary Fig. 1 ). When Mmod was off, the electrical load impedance across the piezo ranged from 10 kΩ to 300 kΩ depending on the power consumption of the IC. The impedance change during stimulation provided a 1-bit data uplink and safety indicator, informing the external transducer when the mote was stimulating. The completed StimDust mote had maximal dimensions of 3.1 mm length, 1.9 mm width, and 0.89 mm height. The mote volume was 2.2 mm 3 , the convex hull volume was 3.6 mm 3 , and the rectangular bounding box volume was 5.3 mm 3 . For comparison, current deep brain stimulation electrodes are 1.27 mm in diameter, > 7 mm in active length and >70 mm in implanted length 40, 41 . A more aggressively scaled mote of 0.65 mm 3 in volume was also designed ( Supplementary Fig. 2 ) which used the same system architecture, piezo size, and fabrication techniques. The 2.2 mm 3 mote design was used for all experiments reported in this paper, but the 0.65 mm 3 mote design had no expected difference in performance. The first stimulation pulse of 150 μA for 37 μs was specified by regions A 1 , W 1 , and G 1 . The second stimulation pulse of 300 μA for 110 μs was specified by A 2 , W 2 , and G 2 . These two different dynamically-encoded pulses are less than 500 μs apart. b, Backscatter relative difference (see Methods) for 916 stimulation pulses. A population of successful stim pulses with backscatter values of 'one' bits was taken under good mote operating conditions with verified stim at the outputs. A population of backscatter samples with no stim and backscatter values of 'zero' bits was acquired by operating the mote in an underpowered state such that output stimulation was no longer performed. The two populations show good separation, enabling the use of backscatter as an indicator of successful stimulation. c, A mote was operated while its depth was scanned relative to a fixed external transducer acoustic field, yielding a viable region in depth. This was performed with the 25.4 mm diameter external transducer at 31.5 V pk-pk transmit. d, e, f, A mote was operated within a fixed external transducer acoustic field while its position and orientation were scanned across transverse offset and angular offset relative to the mote central axis. Depth was held constant at 48 mm. d, Mote piezo harvest voltage. e, Mote regulated voltage. f, Mote able to stimulate region.
Robust wireless operation in a gel tissue phantom
The error between specified current output and actual current output across all 8 amplitude levels (50 μA to 400 μA) was 2.0% on average and 8.1% maximum (maximum absolute current error of 5.7 μA).
The system achieved up to 2.38 kHz pulse repetition frequency (PRF) while stimulating with a pulse width of 80 μs at 400 μA and minimal compliance limiting. A PRF of 5.05 kHz was achieved with 50 μA current and 80 μs pulse width. Higher frequencies resulted in a VDD droop and compliance-limited 
Mote perormance with dynamic programmability in gel phantom
current output, though absolute maximum PRF was 16 kHz. Piezo impedance modulation via the Mmod switch for uplink data modulation showed a drastic amplitude change in VPz+ ( Fig. 5a ). At the external transceiver, the actual uplink bit error rate (BER) ( Fig. 5b ) was 0 out of 880 and the estimated Gaussian fit BER was 9.9 x 10 -8 .
The minimum acoustic field peak intensity under which the mote could power up and stimulate was 142 mW/cm 2 derated ISPTA with a mechanical index of 0.049 (pressure amplitude of 66.1 kPa), 20% and 2.6%, respectively, of the FDA limits for diagnostic ultrasound 34 . While keeping derated ISPTA at the FDA limit, a mote operating in a gel tissue phantom achieved a stimulation of 89 μW (23 nC and 37 nJ per pulse at 2380 Hz), and the power efficiency from acoustic domain to applied electrical stimulation power was 1.9% (Supplementary Section 1 and Supplementary Table 1 ).
The use of an ultrasonic link over an EM one was crucial for achieving high link efficiencies at submm transducer sizes and cm-depths in tissue. An important consideration for the practical deployment of such a system is understanding the effect of acoustic link alignment. Attenuation in body tissues is greater than that of ultrasound gel, reducing the maximum depth of operation. In fat, liver, and muscle tissue (1.1 dB/cm, 1.78 dB/cm, 2.2 dB/cm attenuation, respectively, at 1.85 MHz 42, 43 ), the maximum depth of operation is estimated to be 62 mm, 56 mm, and 51 mm, respectively. These distances can be improved by using an external transducer with longer focal length and larger diameter. The external interrogator set the downlink ultrasound envelope from on to off, and after a short delay, began to capture the backscatter signal x S,0 from the mote from the S 0 period ((b), middle ... ... Voltage (V) In vivo stimulation elicited robust and repeatable compound action potentials and was demonstrated across four different motes. Two of the motes had overlaying tissue flaps replaced and sutured after implantation and were operated through tissue ( Fig. 6 , Supplementary Video 1). The acoustic field ( Supplementary Fig. 3 ) had a derated ISPPA and ISPTA of 713 mW/cm 2 and mechanical index of 0.11, both below the FDA limits of 720 mW/cm 2 and 1.9, respectively, for ultrasound diagnostic imaging 34 , and lower than thresholds for directly ultrasound-mediated stimulation (Supplementary Section 2). In vivo EMG response was controlled by varying stimulation current from 50 µA to 400 µA with fixed 392 µs pulse width (Fig. 7a-c) . The low standard deviation of the CMAP waveforms (line width in Fig.   7a , d) indicated highly repeatable stimulation and biological response across pulses. The recruitment curve as a function of stimulation current (Fig. 7c ) showed a threshold of activation between 200 µA and 250 µA and saturation between 350 µA and 400 µA. The CMAP amplitude saturated at 4.4 mV.
Precise stimulation in vivo
In vivo EMG response was also controlled by varying stimulation pulse width with fixed 400 µA (Fig. 7d-f ). The CMAP amplitude response showed the duration-threshold of elicitation of action potential at 400 μA current to be approximately 26 μs, with response saturation around 150 μs and maximum CMAP amplitude of 4.2 mV.
A second set of current-control and pulse-width-control sweeps were performed two hours after the first ( Supplementary Fig. 5 ). Wireless link performance, communications, and stimulation output were unchanged. The biological response was very similar but showed recruitment curves shifted slightly left, indicating a 15% reduced threshold of recruitment, and 11% lower CMAP amplitude saturation.
These slight differences were potentially due to impedance changes at the electrodes and excitability in the nerve as the tissue began to responds to the implant, muscle fatigue (though pulse repetition frequency was low), or changes in the plane of anesthesia.
In vivo stimulation across pulse repetition frequencies from 0.22 Hz to 2.22 kHz yielded four regimes of muscle activation. Pulse width and current were fixed at 52 μs and 400 μA. By visually observing muscle twitch response, we qualitatively reported single twitches at 0.25, 0.33, 1, 2, 5, and 10 Hz, unfused tetanus at 32 Hz, and fused tetanus at 100 and 320 Hz. This matched expected muscle responses for rat gastrocnemius 45 . At 2 kHz and 2.22 kHz (Fig. 6g ), we observed a single initial twitch and then apparent relaxation. While we did not measure muscle force in this study and thus could not positively confirm nerve block, nerve block has been reported at 2 kHz stimulation frequency and 1 V drive voltage (approximately 666 μA) 46 . Therefore, while not conclusive, these observations were consistent with the system performing nerve block.
Discussion
Our results indicated that repeatable, controlled compound action potentials can be elicited by the 32, 31, 22, 25, 23, 47 . Wireless ultrasonic power and data delivery enabled implant operation at a depth of 70 mm in ultrasound gel. Additionally, direct control of the stimulation waveform by the received ultrasound boasted several advantages over state-of-the-art. Compared to systems that program motes via a bitstream, StimDust achieved sub-µs (1/fcarrier) temporal resolution with a larger dynamic range for pulse width, interphase gap, and PRF because the complexity was pushed to the external transceiver, which had fewer computational and power constraints. Stimulators which used only passive components 22,23 used a direct control scheme as well; however, the stimulation intensity was dictated by the received power and the output was voltage stimulation which is sensitive to electrode properties. Furthermore, they did not feature an uplink whereas StimDust included a wireless uplink via ultrasonic backscatter for safety monitoring and alignment. Active rectification increased efficiency and established a ground reference potential, enabling StimDust to use passive recharge to save power relative to biphasic stimulation while clearing residual stimulation charge on the electrodes, which other direct control systems 22, 23 were unable to do. Using an enable signal, or The use of ultrasound as the wireless power carrier enabled direct voltage harvest from the mote piezo of up to ~7 Vpk-pk and ~3.5 V rectified under safe ultrasound intensity levels, which is sufficient for stimulation with low-impedance electrodes. We chose to take advantage of this to optimize for high power-efficiency rectification. While operating at clinically relevant depths of multiple centimeters, this enabled our high PRF (and high total Pstimulation), which is important for some clinical use cases such as nerve block. The acoustic-to-electrical power conversion could have alternatively been optimized for voltage efficiency rather than power efficiency which would have enabled greater depth of operation or a thinner piezo (both of which reduce mote piezo voltage) at the expense of maximum PRF and Pstimulation.
An important use case for a wireless neural stimulator is placing the mote in the brain for use in DBS and brain-machine interfacing. While establishing an ultrasonic power and communications link through the skull is challenging due to the greater attenuation in skull than in soft tissues, transcranial ultrasound has been shown to safely achieve ultrasonic power levels in the brain of 159 mW/cm 2 at 2 Mhz and a focal depth of 4.5 cm 48, 49 . StimDust is able to operate at a power level (142 mW/cm2) and frequency (1.85 MHz) lower than this, indicating applicability to transcranial and deep-brain operation.
We have introduced the smallest wireless neural stimulator that can deliver current-controlled stimulation. Compact mote integration and programmable stimulation was enabled by a custom wireless ultrasound protocol and an energy efficient integrated circuit. We demonstrated its use fully Following electroplating, the IC was attached to the PCB using a conductive silver epoxy (H20E, Epoxy Technology Inc., Billerica, MA) ( Fig. 4b ) and cured at 150 °C for 10 minutes. The IC and PCB were then cleaned in acetone, followed by isopropyl alcohol and DI water to clean the device prior to wirebonding. The IC was wirebonded to the PCB using an ultrasonic wedge wirebonder (7400B, West
Bond, Scotts Valley, CA) and potted in UV-curable epoxy (AA 3526, Loctite, Düsseldorf, Germany) to protect the wirebonds.
Next, a 750 µm x 750 µm x 750 µm lead-zirconate titanate (PZT) cube (841, APC Int., Mackeyville, PA) and an 0201 surface mount capacitor for charge storage were attached to the PCB using silver epoxy and cured at 150 °C for 10 minutes. PZT was chosen for its high electromechaincal coupling constant and relatively low loss tangent enabling good voltage and power harvest in semi-continuous-wave applications. Barium titanate piezoceramic could also be used for improved biocompatibility, but with a slight reduction in electromechanical coupling coefficient. The PZT coupon was diced from a 750 µm thick sheet of PZT, premetallized with 12 µm of fired-on silver, using a wafer-dicing saw with a ceramic-cutting blade. To complete the circuit, the top terminal of the PZT coupon was wirebonded to the PCB.
The devices were then coated with roughly 10 µm of parylene-C for insulation using chemical vapor deposition (Specialty Coating Systems, Indianapolis, IN). Parylene was chosen as the insulation material due to its excellent properties as a moisture and chemical barrier 51 . Furthermore, because parylene can be precisely deposited with thicknesses on the order of microns, it does not damp the vibrations of the piezoceramic as strongly as other insulation materials such as polydimethylsiloxane (PDMS) or epoxy, allowing for higher efficiency power harvesting. The stimulation electrodes were exposed by gently scoring the parylene around the electrodes using a tungsten probe tip and peeling the parylene away. The parylene encapsulation used in this work is expected to last from several months to a few years in the biological environment 52 . Implementation of recent advances for long-term conformal encapsulation for mm-scale implantable devices could enable decades-or lifetimelongevity 53, 54 .
To aid in surgical placement of the mote on the rat sciatic nerve, a cuff was affixed to the back of the mote. The cuff was made by cutting a small piece of silicone tubing (0.8 mm ID, 1.6 mm OD) to roughly the length of the mote. The tubing was then cut in half and attached next to the electrodes using UV-curable epoxy and silicone adhesive.
A further-miniaturized revision of the StimDust mote was also designed ( Supplementary Fig. 2 ). For this design, an IC was fabricated with its size reduced by removing unnecessary test circuits and debug pads and using pad-over-circuit. Additional size reduction in the mote design came from the use of a 0.5 mm x 0.25 mm footprint storage capacitor and refinement of component and wirebond placement.
While this smaller design was not used for the experiments reported in this paper, it did achieve a size with maximal dimensions of 1.17 mm length, 0.77 mm width, 0.89 mm height, 0.65 mm 3 volume, 0.7 mm 3 convex hull volume, and 0.8 mm 3 rectangular bounding box volume. This design is substantially smaller than the tip of a DBS lead.
Design of the external transceiver:
The external transceiver was a compact device designed to be held by a user with its ultrasonic transducer head placed against the skin of a subject. A previous version demonstrated that the external transceiver could also be configured as a wearable device with a low-profile transducer 55 . The transceiver established an ultrasonic wireless link with the mote to provide power, control stimulation parameters via time-coded downlink data, and report back whether the mote had successfully applied each stimulation pulse via detecting backscatter modulation. It was designed around two major components: a high-performance microcontroller (NXP LPC4370) for system control and digital modulation / demodulation, and a custom ultrasound interface IC 56 This corresponded to the duration when the external transducer was no longer driven, but the acoustic wave was still travelling to and reflecting off the mote. The xS,n-1 region had an amplitude dependent on the mote modulation state during the mote S period, which corresponded to the mote Mmod off. The second backscatter region, xW,n, was captured immediately after the transceiver Wn to Gn transition and also had a duration of two TOF. This region had an amplitude dependent on the mote modulation state during the mote W period. When the mote was properly stimulating, Mmod was on during this region, otherwise Mmod was off. When turned on, Mmod reduced the electrical impedance seen by the mote piezo ( Supplementary Fig. 1 ), reducing the amplitude of the backscattered wave.
To detect the modulation or uplink data for each pulse n (dn), the normalized difference between the time-integrated amplitudes (L1 norms) of the xW,n and xS,n-1 backscatter signals were compared to a threshold.
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The normalization canceled out any variation due to downlink power or path loss. With calibration, a threshold was determined which separates the backscatter relative difference into "1" bits below the threshold and "0" bits above the threshold. Either the L1 norm (volt-seconds) or the L2 norm (backscatter energy in Joules) could be used for this comparison, but L1 showed slightly better separation between backscatter states. This single-bit backscattered data from the mote, which signified whether the mote was stimulating or not, was given as feedback to the operator of the handheld external interrogator via an LED when the mote was detected as active. The backscatter bit and raw backscatter digitized waveforms could also be streamed to a PC via a serial connection for further logging and diagnostics, though this was not necessary for normal operation (backscatter data presented in the figures came from this offload connection).
Characterization of motes in ultrasound gel tissue phantom:
To assess performance of the system, a mote with test leads was placed in ultrasound gel (Aquasonic Clear, Parker Labs, Fairfield NJ), either freely-floating or mounted on top of a 700 μm diameter steel rod connected to a rotation stage (RP01, Thorlabs, Newton, NJ). Bubbles were removed from all ultrasound gel used in this study via centrifugation for 16 minutes at 428 x g to 1052 x g. Ultrasound gel has acoustic impedance and attenuation within 0.7% and 1.9%, respectively, of those of water 58 . An electrical load was attached to the mote electrode terminals to mimic tissue electrical properties (series 3 kΩ and 22 nF were used; note that in-vivo values were RSoln = ~4.54 kΩ and Cdl = ~17.9 nF). The external transceiver was mounted to a computer-controlled 2-axis stage (XSlide, VelMex) with the external transducer contacting the gel. Mote parameter encoding and decoding performance were assessed at a mote depth of 18 mm using the 12.7 mm diameter external transducer at a transmit voltage of 19.4 Vpk-pk.
Stimulation, power and backscatter performance were assessed at a mote depth of 48 mm using the 25.4 mm diameter external transducer at a transmit voltage of 25.6 Vpk-pk. Backscatter modulation uplink performance was assessed by determining the separation of demodulated 'one' bits and 'zero' bits. 'One' bits were gathered with a fully-powered mote showing a high relative difference between the modulation states (Mmod off during Sn-1 and Mmod on during Wn). 'Zero' bits were gathered by operating a mote slightly underpowered so that stimulation did not occur and there was a low relative difference between the modulation states (Mmod off during Sn-1 and Mmod off during Wn). The VPz-, VDD, Velec) ( Fig. 1c) . These leads were unnecessary for the function of the mote and were used for debugging, recording wired data to compare with the wireless readout for characterization purposes, and to standardize the fine-alignment of the acoustic link; they provided no power or communication signals to the mote. To ensure that these leads had no effect on the performance of the system, they were completely disconnected from all external instrumentation during a test trial and no change in system performance was seen.
For initial verification of functional stimulation and sweeps of stimulation current and pulse width, the surgical site was left open and the external interrogator was mounted such that the external transducer face was approximately 20 mm from the mote, with ultrasound gel filling the intervening space. The external interrogator was then turned on and chip VDD was measured from test leads on the mote. The external interrogator position was adjusted to ensure good fine-alignment with the mote and successful stimulation was verified with test leads on the mote. This use of a measure of VDD for fine alignment of the mote was used for repeatability between trials but was not necessary for function of the system.
To verify this, positioning of the external transducer relative to the mote was performed without using VDD as an alignment reference and the mote was able to receive enough power to function. The backscatter amplitude was also an option to aid in positioning the mote without use of a VDD measurement.
Two penetrating stainless-steel electrodes were placed in the gastrocnemius muscle to capture the electromyogram signal (EMG) induced by sciatic nerve stimulation. The EMG signal was amplified by 1000X, bandpass filtered at 10 Hz to 3 kHz (DP-304, Warner Instr. Co., Hamden CT), and digitized at 100 kSPS (NI DAQ USB 6001, NI, Austin TX).
The external interrogator was programmed to specify a stimulation current, pulse width, and pulse repetition frequency. The system was initiated and performed approximately 30 to 60 stimulation events per condition before being set to different stimulation parameters. The pulse repetition frequency was kept at a relatively low ~1/3 Hz while generating recruitment curves to prevent muscle fatigue.
Stimulation of the sciatic nerve elicited compound muscle action potentials (CMAP) across much of the lower leg musculature. CMAP amplitudes were calculated from baseline to the first peak. To calibrate the stimulation response curve, mote parameters were swept across stimulation current and stimulation pulse width dimensions, and baseline-to-peak CMAP amplitudes were calculated to construct a recruitment curve. A sweep of pulse repetition frequency was also performed and qualitative muscle response recorded.
To verify that the acoustic link was functional while transmitting through the tissue layer of the animal, the experiment was repeated with a closed surgical site. Excess ultrasound gel was removed, the biceps femoris replaced over the nerve and mote, and the skin incision sutured with 6-0 nylon suture. With the wound closed, ultrasound gel was applied to the outside of the animal and the external interrogator was repositioned with the external transducer in contact with gel so that the distance from transducer to mote was 18 mm, with approximately 5 mm consisting of tissue. Downlink, stimulation, and uplink performance were then assessed with the fully implanted mote.
To characterize in vivo telemetry, backscatter modulation was detected as described above. The relative difference between the L1 norms of these two regions was calculated for 111 successful in vivo stimulation pulses ( Fig. 6e left population) . The relative difference between the L1 norms of the Sn and Sn+1 backscatter regions was calculated for the same 111 pulses ( Fig. 6e right population) and
was used as an estimate of the backscatter when Mmod does not turn on during the W phase (which is the case when the mote does not stimulate). The power performance of the system was measured for two conditions: benchtop operation at high PRF and in vivo operation with a fully implanted mote at low PRF (Supplementary Table 1 ). VTX and Pelectrical into the external transducer were measured at the output of the external power supply used to supply the ultrasound interface chip. The external transducer was heavily damped to shorten its impulse response and much of the acoustic power generated in the external transducer piezo was dumped into the absorptive backing layer, causing the electrical input power to acoustic power at the focal plane efficiency to be low.
Supplemental Information
Acoustic domain measurements were made with a hydrophone in water; notably, the hydrophone measurements were taken in a separate experiment from mote operation and the acoustic values in table 1 assume that the mote was positioned at the point of maximal acoustic intensity (this may cause up to ~20% error). For the in vivo condition, the hydrophone measurements could not be made directly, and so expected loss from impedance mismatches and absorption in 2 mm of skin and 3 mm of muscle ( 42 , 59 , 43 ) was modeled to yield an estimate of acoustic intensity inside the animal. The acoustic power at the focal plane (depth of the mote) was integrated over a 1 cm radius circle, which is at least 97% of The acoustic power conversion efficiency (ηacoustic) is defined as the ratio of the electrical power used to charge to the mote relative to the acoustic power at the face of the mote piezo. This efficiency encompasses the acoustic to electrical power efficiency of the piezo, the rectifier efficiency, and the standby power consumption of the IC. It was calculated from the measured rate of change of the Cstore capacitor voltage (VDD) during initial mote power-up for a 3V VDD steady-state. Under a given incident acoustic power, the ηacoustic (as measured by P into Cstore) peaked at ~8.1% when VDD was near half the steady-state voltage ( Fig. 6f, Supplementary Fig. 4 ). Note that at low PRF the total Pstimulation_delivered was low and the device charged up quickly and remained 'idle' for most of the time between stimulation pulses yielding a low overall efficiency. Under low PRF conditions, it was shown that the device could be intermittently powered up for each pulse to reduce the overall ultrasound dose. If optimized for this application, the mote could have a small Cstore to reduce startup time. Fig. S4 | In vivo power harvesting performance during initial power-up. a, After 4.2 s without receiving power, the mote V DD (V across C store ) was ~0.7 V. When downlink power resumed (at t = 0), the 4 μF C store charged over ~300ms. b, The charging waveform from (a) was used to estimate the efficiency during charging as VDD passed through various regimes. η acoustic is the ratio of electrical power used for charging the mote to acoustic power at the face of the mote piezo. At 1.2 V DD , the rate of electrical power harvest was maximum but V DD was below the POR cutoff and the device did not stimulate. Between 1.9 V DD and 3.0 V DD , the mote was able to stimulate. Power harvest efficiency was moderate at 1.9 V DD and decreased to very low values at 3.0 V DD , which was the point where C store was nearly topped off and 'trickle charging' under the given incident acoustic power conditions. At 1.85 MHz, the threshold of ultrasound-mediated neural stimulation has been reported at approximately 10 W/cm 2 pulse-average intensity 60 ; this is more than 14x higher intensity than that used in this study. Furthermore, as the system increased stimulation current from 50 μA to 400 μA with a corresponding recruitment of CMAP response, acoustic power was nearly identical and actually decreased slightly since the protocol utilizes a longer TDC gap when specifying high current.
Additionally, no EMG response was observed when the system was driven with continuous ultrasound at the same intensity as used for controlling the device, but with no coded downlink signals. Finally, a pilot in vivo experiment, which powered the mote electrically with no ultrasound, produced stimulation and evoked CMAP's identical to those evoked with an acoustically-powered mote (data not shown).
Utilizing a current-control implantable stimulator provides improved stimulation precision and spatial resolution as compared to directly mediated ultrasonic stimulation, and requires substantially lower acoustic intensities and thus has lower risk from ultrasound-induced thermal or cavitation damage 61 . 
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